Showing results (461-470 of 567) with videos related to
Sort By:
Pageof 57
Investigational New Drugs|January 29, 2013
A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortiumSrikala S Sridhar, Mary J Mackenzie, Sebastien J Hotte, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancerJ Bellmunt, B J Eigl, E Senkus, et al.American Journal of Clinical Oncology|January 1, 2010
A multicenter phase II clinical trial of lapatinib (GW572016) in hormonally untreated advanced prostate cancerSrikala S Sridhar, Sebastien J Hotte, Joseph L Chin, et al.Archives of Otolaryngology--Head & Neck Surgery|August 7, 2002
The role of intratumoral therapy with cisplatin/epinephrine injectable gel in the management of advanced squamous cell carcinoma of the head and neckBarry L Wenig, Jochen A Werner, Dan J Castro, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2013
Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trialsA J Templeton, F E Vera-Badillo, L Wang, et al.The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
Combination Treatment for Management of Chronic Kidney Disease and Type 2 Diabetes: A Review and Practical GuidanceMai Mohsen, Tae Won Yi, Labib Faruque, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
Canadian experience of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy for muscle-invasive bladder cancerKhaled Ajib, Michael C Tjong, Guan Hee Tan, et al.Clinical Kidney Journal|February 26, 2025
Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implicationsDavid León-Jiménez, Vikas S Sridhar, Manuel López-Mendoza, et al.Clinical Genitourinary Cancer|October 29, 2017
The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate CancerDaniel Heinrich, Jasmin Bektic, Andries M Bergman, et al.Urologic Oncology|May 21, 2014
Examining the management of muscle-invasive bladder cancer by medical oncologists in the United StatesAndrea B Apolo, Joseph W Kim, Bernard H Bochner, et al.Pageof 57